Escalon Medical Corp. (ESMC)
USD 0.14
(16.67%)
USD 0.14
(16.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 524.71 Thousand USD | -41.03% |
| 2023 | 889.87 Thousand USD | -26.15% |
| 2022 | 1.2 Million USD | -32.0% |
| 2021 | 1.77 Million USD | -13.2% |
| 2020 | 2.04 Million USD | 828.56% |
| 2019 | 219.87 Thousand USD | 18.09% |
| 2018 | 186.19 Thousand USD | -76.58% |
| 2017 | 795 Thousand USD | 189.09% |
| 2016 | 275 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 4.14 Million USD | -13.27% |
| 2011 | 4.78 Million USD | 14.71% |
| 2010 | 4.17 Million USD | -31.81% |
| 2009 | 6.11 Million USD | 712.61% |
| 2008 | 752.62 Thousand USD | 401.08% |
| 2007 | 150.2 Thousand USD | -62.01% |
| 2006 | 395.38 Thousand USD | -36.45% |
| 2005 | 622.13 Thousand USD | -85.42% |
| 2004 | 4.26 Million USD | -35.0% |
| 2003 | 6.56 Million USD | -23.0% |
| 2002 | 8.52 Million USD | -19.99% |
| 2001 | 10.65 Million USD | 3.16% |
| 2000 | 10.33 Million USD | 443.8% |
| 1999 | 1.9 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | -100.0% |
| 1993 | 500 Thousand USD | -37.5% |
| 1992 | 800 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 464.17 Thousand USD | -47.84% |
| 2024 Q3 | 614.13 Thousand USD | -13.22% |
| 2024 Q4 | 524.71 Thousand USD | -14.56% |
| 2024 Q2 | 707.66 Thousand USD | 52.46% |
| 2023 Q1 | 1.13 Million USD | -6.19% |
| 2023 Q4 | 889.87 Thousand USD | -8.52% |
| 2023 FY | 889.87 Thousand USD | -26.15% |
| 2023 Q3 | 972.78 Thousand USD | -7.64% |
| 2023 Q2 | 1.05 Million USD | -6.82% |
| 2022 Q4 | 1.2 Million USD | 14.15% |
| 2022 FY | 1.2 Million USD | -32.0% |
| 2022 Q1 | 1.2 Million USD | -31.96% |
| 2022 Q2 | 1.13 Million USD | -6.17% |
| 2022 Q3 | 1.05 Million USD | -6.7% |
| 2021 Q3 | 1.84 Million USD | -3.49% |
| 2021 Q2 | 1.9 Million USD | -3.38% |
| 2021 FY | 1.77 Million USD | -13.2% |
| 2021 Q1 | 1.97 Million USD | -3.22% |
| 2021 Q4 | 1.77 Million USD | -3.81% |
| 2020 Q2 | 1.25 Million USD | -6.43% |
| 2020 Q4 | 2.04 Million USD | 39.38% |
| 2020 FY | 2.04 Million USD | 828.56% |
| 2020 Q1 | 1.34 Million USD | 511.54% |
| 2020 Q3 | 1.46 Million USD | 16.43% |
| 2019 Q4 | 219.87 Thousand USD | -0.37% |
| 2019 FY | 219.87 Thousand USD | 18.09% |
| 2019 Q3 | 220.67 Thousand USD | -0.36% |
| 2019 Q2 | 221.47 Thousand USD | -0.35% |
| 2019 Q1 | 222.25 Thousand USD | 19.37% |
| 2018 FY | 186.19 Thousand USD | -76.58% |
| 2018 Q1 | 870 Thousand USD | 9.43% |
| 2018 Q2 | 835 Thousand USD | -4.02% |
| 2018 Q3 | 186.94 Thousand USD | -77.61% |
| 2018 Q4 | 186.19 Thousand USD | -0.4% |
| 2017 Q4 | 795 Thousand USD | 0.0% |
| 2017 FY | 795 Thousand USD | 189.09% |
| 2017 Q1 | 275 Thousand USD | 0.0% |
| 2017 Q2 | 792 Thousand USD | 188.0% |
| 2017 Q3 | 795 Thousand USD | 0.38% |
| 2016 Q3 | 150 Thousand USD | -99.99% |
| 2016 Q1 | 1.28 Billion USD | -15.81% |
| 2016 Q2 | 1.4 Billion USD | 9.11% |
| 2016 Q4 | 275 Thousand USD | 83.33% |
| 2016 FY | 275 Thousand USD | 0.0% |
| 2015 Q3 | 1.32 Billion USD | 16.61% |
| 2015 Q1 | 1.02 Billion USD | -12.74% |
| 2015 Q4 | 1.52 Billion USD | 15.51% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | 1.13 Billion USD | 11.22% |
| 2014 Q4 | 1.16 Billion USD | 3.34% |
| 2014 Q1 | 910.72 Million USD | -22.25% |
| 2014 Q3 | 1.13 Billion USD | 7.93% |
| 2014 Q2 | 1.04 Billion USD | 15.17% |
| 2014 FY | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | 1.17 Billion USD | 54.99% |
| 2013 Q3 | 755.69 Million USD | -17.68% |
| 2013 Q2 | 918.04 Million USD | 22024.1% |
| 2013 Q1 | 4.14 Million USD | 0.0% |
| 2012 Q4 | 4.14 Million USD | 0.0% |
| 2012 FY | 4.14 Million USD | -13.27% |
| 2012 Q1 | 4.42 Million USD | -7.43% |
| 2012 Q2 | 4.44 Million USD | 0.46% |
| 2012 Q3 | 4.14 Million USD | -6.74% |
| 2011 FY | 4.78 Million USD | 14.71% |
| 2011 Q4 | 4.78 Million USD | 0.55% |
| 2011 Q3 | 4.75 Million USD | 6.38% |
| 2011 Q2 | 4.47 Million USD | -2.64% |
| 2011 Q1 | 4.59 Million USD | 10.15% |
| 2010 FY | 4.17 Million USD | -31.81% |
| 2010 Q2 | 6.11 Million USD | -2.76% |
| 2010 Q1 | 6.29 Million USD | 2.88% |
| 2010 Q3 | 5.73 Million USD | -6.26% |
| 2010 Q4 | 4.17 Million USD | -27.28% |
| 2009 FY | 6.11 Million USD | 712.61% |
| 2009 Q4 | 6.11 Million USD | 3.83% |
| 2009 Q3 | 5.89 Million USD | -7.78% |
| 2009 Q2 | 6.38 Million USD | 918.42% |
| 2009 Q1 | 627.18 Thousand USD | -16.67% |
| 2008 Q2 | 54.55 Thousand USD | -42.37% |
| 2008 Q3 | 13.22 Thousand USD | -75.75% |
| 2008 Q4 | 752.62 Thousand USD | 5589.62% |
| 2008 FY | 752.62 Thousand USD | 401.08% |
| 2008 Q1 | 94.65 Thousand USD | -36.98% |
| 2007 Q2 | 286.93 Thousand USD | -14.53% |
| 2007 Q1 | 335.71 Thousand USD | -15.09% |
| 2007 FY | 150.2 Thousand USD | -62.01% |
| 2007 Q4 | 150.2 Thousand USD | -29.51% |
| 2007 Q3 | 213.07 Thousand USD | -25.74% |
| 2006 Q4 | 395.38 Thousand USD | -15.64% |
| 2006 FY | 395.38 Thousand USD | -36.45% |
| 2006 Q3 | 468.68 Thousand USD | -8.28% |
| 2006 Q2 | 510.99 Thousand USD | -9.17% |
| 2006 Q1 | 562.59 Thousand USD | -9.57% |
| 2005 Q1 | 2 Million USD | -53.07% |
| 2005 Q2 | 758.63 Thousand USD | -62.12% |
| 2005 FY | 622.13 Thousand USD | -85.42% |
| 2005 Q3 | 689.41 Thousand USD | -9.12% |
| 2005 Q4 | 622.13 Thousand USD | -9.76% |
| 2004 Q3 | 4.67 Million USD | -7.97% |
| 2004 Q4 | 4.26 Million USD | -8.67% |
| 2004 FY | 4.26 Million USD | -35.0% |
| 2004 Q2 | 5.07 Million USD | -11.1% |
| 2004 Q1 | 5.71 Million USD | -13.02% |
| 2003 Q2 | 7.77 Million USD | -5.03% |
| 2003 Q4 | 6.56 Million USD | -10.35% |
| 2003 FY | 6.56 Million USD | -23.0% |
| 2003 Q3 | 7.32 Million USD | -5.85% |
| 2003 Q1 | 8.19 Million USD | -3.95% |
| 2002 Q1 | 9.98 Million USD | -6.34% |
| 2002 Q4 | 8.52 Million USD | -6.73% |
| 2002 FY | 8.52 Million USD | -19.99% |
| 2002 Q3 | 9.14 Million USD | -3.02% |
| 2002 Q2 | 9.42 Million USD | -5.56% |
| 2001 Q3 | 11.18 Million USD | 8.57% |
| 2001 Q1 | 10.65 Million USD | 3.09% |
| 2001 Q2 | 10.3 Million USD | -3.29% |
| 2001 Q4 | 10.65 Million USD | -4.69% |
| 2001 FY | 10.65 Million USD | 3.16% |
| 2000 Q3 | 12.5 Million USD | 594.73% |
| 2000 Q1 | 900 Thousand USD | -52.63% |
| 2000 FY | 10.33 Million USD | 443.8% |
| 2000 Q4 | 10.33 Million USD | -17.38% |
| 2000 Q2 | 1.8 Million USD | 100.0% |
| 1999 Q3 | 1 Million USD | 0.0% |
| 1999 Q4 | 1.9 Million USD | 90.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | 1.9 Million USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 FY | - USD | -100.0% |
| 1994 Q1 | - USD | -100.0% |
| 1993 Q4 | 500 Thousand USD | 400.0% |
| 1993 FY | 500 Thousand USD | -37.5% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q2 | 100 Thousand USD | 0.0% |
| 1993 Q3 | 100 Thousand USD | 0.0% |
| 1992 FY | 800 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -16.738% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -774.532% |
| Össur hf. | 467.73 Million USD | 99.888% |
| QHSLab, Inc. | 1.78 Million USD | 70.547% |
| Wellstar International, Inc. | 51.36 Million USD | 98.978% |
| Össur hf. | 467.73 Million USD | 99.888% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Aurora Spine Corporation | 2.67 Million USD | 80.352% |
| BrainsWay Ltd. | 471 Thousand USD | -11.405% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 14.83 Million USD | 96.462% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 98.113% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -5.705% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -194.597% |
| Zecotek Photonics Inc. | 3.22 Million USD | 83.714% |
| Avitar, Inc. | 5.26 Million USD | 90.034% |
| Nanomix Corporation | 11.4 Million USD | 95.4% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 89.944% |
| Theraclion SA | 1.95 Million EUR | 73.101% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | 70.646% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 69.108% |
| Lombard Medical, Inc. | 32.29 Million USD | 98.375% |
| ALR Technologies Inc. | 19.26 Million USD | 97.276% |
| Stratec SE | 156.16 Million USD | 99.664% |
| Vycor Medical, Inc. | 1.11 Million USD | 52.739% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -150.72% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.969% |
| VMS Rehab Systems, Inc. | 133.52 USD | -392889.065% |
| NewCardio, Inc. | 3 Million USD | 82.509% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 74.503% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 16.864% |
| Odyssey Group International, Inc. | 2.14 Million USD | 75.534% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 21.684% |
| Wellness Center USA, Inc. | 4.04 Million USD | 87.018% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 98.357% |
| IR-Med Inc. | 161 Thousand USD | -225.912% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -172.025% |
| Polarean Imaging plc | 216.38 Thousand USD | -142.493% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 3.17 Million USD | 83.454% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -424.719% |
| Capital Group Holdings, Inc. | 4944.00 USD | -10513.248% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 34.382% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -131.152% |
| Urologix, Inc. | 5.33 Million USD | 90.161% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 86.302% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 87.552% |
| SS Innovations International, Inc. | 8.21 Million USD | 93.615% |
| Qualis Innovations, Inc. | 9102.00 USD | -5664.876% |
| Smith & Nephew plc | 3.07 Billion USD | 99.983% |
| NIOX Group Plc | 1.4 Million USD | 62.528% |
| Fuse Medical, Inc. | 1.99 Million USD | 73.681% |
| Broncus Holding Corporation | 2.35 Million USD | 77.713% |
| Brain Scientific Inc. | 2.86 Million USD | 81.676% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 97.694% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -1197.461% |